Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where William T. Lowrance is active.

Publication


Featured researches published by William T. Lowrance.


Cancer | 2010

Trends in Renal Tumor Surgery Delivery Within the United States

Lori M. Dulabon; William T. Lowrance; Paul Russo; William C. Huang

Most small renal tumors are amenable to partial nephrectomy (PN). Studies have documented the association of radical nephrectomy (RN) with an increased risk of comorbid conditions, such as chronic kidney disease. Despite evidence of equivalent oncologic outcomes, PN remains under used within the United States. In this study, the authors identified the most recent trends in kidney surgery for small renal tumors and determined which factors were associated with the use of PN versus RN within the United States.


The Journal of Urology | 2008

Contemporary Open Radical Cystectomy: Analysis of Perioperative Outcomes

William T. Lowrance; Jon A. Rumohr; Sam S. Chang; Peter E. Clark; Joseph A. Smith; Michael S. Cookson

PURPOSE The feasibility of laparoscopic or robotic assisted radical cystectomy has been demonstrated in several small series, but the specific advantages are uncertain and require comparisons to more recent results that incorporate refinements in open technique and perioperative management. We reviewed our contemporary radical cystectomy series to evaluate perioperative outcome measures which could be affected by surgical approach for the purpose of establishing contemporary benchmarks for future comparisons. MATERIALS AND METHODS The medical records of 553 consecutive patients undergoing radical cystectomy from January 2000 through June of 2005 were reviewed. Perioperative and demographic data, type of urinary diversion, hospital stay, complications and perioperative mortality were examined. RESULTS Median patient age was 69 years (range 22 to 94) and average American Society of Anesthesiologists classification was 2.7. Median operative time was 258 minutes (range 89 to 801). Mean operative time for ileal conduit diversion was 271 vs 312 minutes for neobladder diversion. Median blood loss was 600 ml (range 200 to 4,200). A total of 210 patients (38%) received a blood transfusion either intraoperatively or within the first 30 days of their procedure. Median length of hospital stay was 6 days (range 4 to 79). Minor and major complications occurred in 209 (38%) and 41 (7.4%) patients, respectively. Perioperative mortality was 1.7%. CONCLUSIONS These results demonstrate that contemporary radical cystectomy can be accomplished through an open operative approach consistently with acceptable morbidity/mortality and with a median length of stay of less than 1 week. Efforts to further reduce morbidity and improve outcomes should continue.


The Journal of Urology | 2012

Contemporary Open and Robotic Radical Prostatectomy Practice Patterns Among Urologists in the United States

William T. Lowrance; James A. Eastham; Caroline Savage; Alexandra C. Maschino; Vincent P. Laudone; Christopher Dechet; Robert A. Stephenson; Peter T. Scardino; Jaspreet S. Sandhu

PURPOSE We describe current trends in robotic and open radical prostatectomy in the United States after examining case logs for American Board of Urology certification. MATERIALS AND METHODS American urologists submit case logs for initial board certification and recertification. We analyzed logs from 2004 to 2010 for trends and used logistic regression to assess the impact of urologist age on robotic radical prostatectomy use. RESULTS A total of 4,709 urologists submitted case logs for certification between 2004 and 2010. Of these logs 3,374 included 1 or more radical prostatectomy cases. Of the urologists 2,413 (72%) reported performing open radical prostatectomy only while 961 (28%) reported 1 or more robotic radical prostatectomies and 308 (9%) reported robotic radical prostatectomy only. During this 7-year period we observed a large increase in the number of urologists who performed robotic radical prostatectomy and a smaller corresponding decrease in those who performed open radical prostatectomy. Only 8% of patients were treated with robotic radical prostatectomy by urologists who were certified in 2004 while 67% underwent that procedure in 2010. Median age of urologists who exclusively performed open radical prostatectomy was 43 years (IQR 38-51) vs 41 (IQR 35-46) for those who performed only robotic radical prostatectomy. CONCLUSIONS While the rate was not as high as the greater than 85% industry estimate, 67% of radical prostatectomies were done robotically among urologists who underwent board certification or recertification in 2010. Total radical prostatectomy volume almost doubled during the study period. These data provide nonindustry based estimates of current radical prostatectomy practice patterns and further our understanding of the evolving surgical treatment of prostate cancer.


The Journal of Urology | 2009

Contemporary Use of Partial Nephrectomy at a Tertiary Care Center in the United States

R. Houston Thompson; Matthew Kaag; Andrew J. Vickers; Shilajit Kundu; Melanie Bernstein; William T. Lowrance; David J. Galvin; Guido Dalbagni; Karim Touijer; Paul Russo

PURPOSE The use of partial nephrectomy for renal cortical tumors appears unacceptably low in the United States according to population based data. We examined the use of partial nephrectomy at our tertiary care facility in the contemporary era. MATERIALS AND METHODS Using our prospectively maintained nephrectomy database we identified 1,533 patients who were treated for a sporadic and localized renal cortical tumor between 2000 and 2007. Patients with bilateral disease or solitary kidneys were excluded from study and elective operation required an estimated glomerular filtration rate of 45 ml per minute per 1.73 m(2) or greater. Predictors of partial nephrectomy were evaluated using logistic regression models. RESULTS Overall 854 (56%) and 679 patients (44%) were treated with partial and radical nephrectomy, respectively. In the 820 patients treated electively for a tumor 4 cm or less the frequency of partial nephrectomy steadily increased from 69% in 2000 to 89% in 2007. In the 365 patients treated electively for a 4 to 7 cm tumor the frequency of partial nephrectomy also steadily increased from 20% in 2000 to 60% in 2007. On multivariate analysis male gender (p = 0.025), later surgery year (p <0.001), younger patient age (p = 0.005), smaller tumor (p <0.001) and open surgery (p <0.001) were significant predictors of partial nephrectomy. American Society of Anesthesiologists score, race and body mass index were not significantly associated with treatment type. CONCLUSIONS The use of partial nephrectomy is increasing and it is now performed in approximately 90% of patients with T1a tumors at our institution. For reasons that remain unclear certain groups of patients are less likely to be treated with partial nephrectomy.


Journal of The National Comprehensive Cancer Network | 2016

NCCN Guidelines Insights: Prostate Cancer Early Detection, Version 2.2016

Peter R. Carroll; J. Kellogg Parsons; Gerald L. Andriole; Robert R. Bahnson; Erik P. Castle; William J. Catalona; Douglas M. Dahl; John W. Davis; Jonathan I. Epstein; Ruth Etzioni; Thomas A. Farrington; George P. Hemstreet; Mark H. Kawachi; Simon P. Kim; Paul H. Lange; Kevin R. Loughlin; William T. Lowrance; Paul Maroni; James L. Mohler; Todd M. Morgan; Kelvin A. Moses; Robert B. Nadler; Michael A. Poch; Charles D. Scales; Terrence M. Shaneyfelt; Marc C. Smaldone; Geoffrey A. Sonn; Preston Sprenkle; Andrew J. Vickers; Robert W. Wake

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prostate Cancer Early Detection provide recommendations for prostate cancer screening in healthy men who have elected to participate in an early detection program. The NCCN Guidelines focus on minimizing unnecessary procedures and limiting the detection of indolent disease. These NCCN Guidelines Insights summarize the NCCN Prostate Cancer Early Detection Panels most significant discussions for the 2016 guideline update, which included issues surrounding screening in high-risk populations (ie, African Americans, BRCA1/2 mutation carriers), approaches to refine patient selection for initial and repeat biopsies, and approaches to improve biopsy specificity.


The Journal of Urology | 2010

Comparative Effectiveness of Prostate Cancer Surgical Treatments: A Population Based Analysis of Postoperative Outcomes

William T. Lowrance; Elena B. Elkin; Lindsay M. Jacks; David S. Yee; Thomas L. Jang; Vincent P. Laudone; Bertrand Guillonneau; Peter T. Scardino; James A. Eastham

PURPOSE Enthusiasm for laparoscopic surgical approaches to prostate cancer treatment has grown despite limited evidence of improved outcomes compared with open radical prostatectomy. We compared laparoscopic prostatectomy with or without robotic assistance vs open radical prostatectomy in terms of postoperative outcomes and subsequent cancer directed therapy. MATERIALS AND METHODS Using a population based cancer registry linked with Medicare claims we identified men 66 years old or older with localized prostate cancer who underwent radical prostatectomy from 2003 to 2005. Outcome measures were general medical/surgical complications and mortality within 90 days after surgery, genitourinary/bowel complications within 365 days, radiation therapy and/or androgen deprivation therapy within 365 days and length of hospital stay. RESULTS Of the 5,923 men 18% underwent laparoscopic radical prostatectomy. Adjusting for patient and tumor characteristics, there were no differences in the rate of general medical/surgical complications (OR 0.93 95% CI 0.77-1.14) or genitourinary/bowel complications (OR 0.96 95% CI 0.76-1.22), or in postoperative radiation and/or androgen deprivation (OR 0.80 95% CI 0.60-1.08). Laparoscopic prostatectomy was associated with a 35% shorter hospital stay (p <0.0001) and a lower bladder neck/urethral obstruction rate (OR 0.74, 95% CI 0.58-0.94). In laparoscopic cases surgeon volume was inversely associated with hospital stay and the odds of any genitourinary/bowel complication. CONCLUSIONS Laparoscopic prostatectomy and open radical prostatectomy have similar rates of postoperative morbidity and additional treatment. Men considering prostate cancer surgery should understand the expected benefits and risks of each technique to facilitate decision making and set realistic expectations.


Cancer | 2011

Temporal trends and predictors of pelvic lymph node dissection in open or minimally invasive radical prostatectomy.

Andrew Feifer; Elena B. Elkin; William T. Lowrance; Brian Denton; Lindsay M. Jacks; David S. Yee; Jonathan A. Coleman; Vincent P. Laudone; Peter T. Scardino; James A. Eastham

Pelvic lymph node dissection (PLND) is an important component of prostate cancer staging and treatment, especially for surgical patients who have high‐risk tumor features. It is not clear how the shift from open radical prostatectomy (ORP) to minimally invasive radical prostatectomy (MIRP) has affected the use of PLND. The objectives of this study were to identify predictors of PLND and to assess the impact of surgical technique in a contemporary, population‐based cohort.


BJUI | 2010

Obesity is associated with a higher risk of clear-cell renal cell carcinoma than with other histologies

William T. Lowrance; R. Houston Thompson; David S. Yee; Matthew Kaag; S. Machele Donat; Paul Russo

Study Type – Prognosis (cohort)
 Level of Evidence 2a


European Urology | 2014

Costs of Radical Prostatectomy for Prostate Cancer: A Systematic Review

Christian Bolenz; Stephen J. Freedland; Brent K. Hollenbeck; Yair Lotan; William T. Lowrance; Joel B. Nelson; Jim C. Hu

CONTEXT Robot-assisted laparoscopic radical prostatectomy (RALP) has been rapidly adopted as a new approach for radical prostatectomy (RP) in patients with prostate cancer (PCa). The use of new technology may increase costs for RP. OBJECTIVE To summarize data on direct costs of various approaches to RP and to discuss the consequences of cost differences. EVIDENCE ACQUISITION A systematic literature search was performed in March 2012 using the PubMed, Web of Science, and Cochrane Library databases. A complex search strategy was applied. Articles were selected according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses criteria. Articles reporting on direct costs of RP (open retropubic [RRP], radical perineal [RPP], laparoscopic [LRP], RALP) in men with clinically localized PCa were eligible for study inclusion. EVIDENCE SYNTHESIS Of 1218 articles initially screened by title, the multistep, systematic search identified 11 studies presenting direct costs of different approaches to RP. Of the 11 studies, 7 compared the costs of different RP approaches. Minimally invasive RP (MIRP) (ie, LRP or RALP) was more expensive than RRP in most studies, mainly due to increased surgical instrumentation costs. In the comparative studies, costs ranged from (in US dollars)


The Journal of Urology | 2015

Gleason 6 prostate cancer: Translating biology into population health

Ketan K. Badani; Daniel A. Barocas; Glen W. Barrisford; Jed Sian Cheng; Arnold I. Chin; Anthony T. Corcoran; Jonathan I. Epstein; Arvin K. George; Gopal N. Gupta; Matthew H. Hayn; Eric C. Kauffman; Brian R. Lane; Michael A. Liss; Moben Mirza; Todd M. Morgan; Kelvin Moses; Kenneth G. Nepple; Mark A. Preston; Soroush Rais-Bahrami; Matthew J. Resnick; Minhaj Siddiqui; Jonathan Silberstein; Eric A. Singer; Geoffrey A. Sonn; Preston Sprenkle; Kelly L. Stratton; Jennifer M. Taylor; Jeffrey J. Tomaszewski; Matt Tollefson; Andrew Vickers

5058 to

Collaboration


Dive into the William T. Lowrance's collaboration.

Top Co-Authors

Avatar

Elena B. Elkin

Memorial Sloan Kettering Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Paul Russo

Memorial Sloan Kettering Cancer Center

View shared research outputs
Top Co-Authors

Avatar

David S. Yee

University of California

View shared research outputs
Top Co-Authors

Avatar

James A. Eastham

Memorial Sloan Kettering Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Michael S. Cookson

University of Alabama at Birmingham

View shared research outputs
Top Co-Authors

Avatar

Peter T. Scardino

Memorial Sloan Kettering Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Yair Lotan

University of Texas Southwestern Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Paul Maroni

University of Colorado Denver

View shared research outputs
Top Co-Authors

Avatar

Sam S. Chang

Vanderbilt University Medical Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge